The Nordic context where public health responsibility is strongly devolved to municipalities raises specific demands on public health research. The demands for causal inference of disease aetiology and intervention efficacy is not different, but in addition there is a need for population health science that describes local prevalence, distribution and clustering of determinants. Knowledge of what interventions and policies work, for whom and under what conditions is essential, but instead of assuming context independence and demanding high external validity it is important to understand how contextual factors linked to groups and places modify both effects and implementation. More implementation studies are needed, but the infrastructure for that research in terms of theories and instruments for monitoring implementation is needed. Much of this was true also 30 years ago, but with increasing spending on both public health research and practice, the demands are increasing that major improvement of population health and health equity are actually achieved.
Background
The Scandinavian countries have all in recent years introduced legislation that, in an already rather decentralized governance structure, devolves public health responsibility and practice to the regional and local government levels. In many policy areas municipalities represent not only an arena for implementation of central policy goals but also represent independent local democratic arenas in which it is decided how to use national and local revenues in accordance with local preferences and needs [1] . This dual role means that local municipalities have to be efficient from a functionalist perspective, delivering services responsive to both local demands and central policy goals. At the same time, they are a forum for integration and participation of citizens in the local community. Both roles are central to developing health policies. This process requires both a high professional level and a high degree of participation, as health policies involve many changes among citizens and other public and private actors.
It is in this context that public health research shall be translated into practice. Efficient and equitable practices have to be based on both local context-specific knowledge of needs and resources as well as more global knowledge on disease aetiology and intervention efficacy. Nordic municipalities are often small and do not have resources or mandate to do their own research and development work but have to apply evidence generated in contexts very different from their own. If public health research is to be relevant for practice it has to deliver on two fronts. It has to produce knowledge for both central and local levels on disease causation and effects of interventions and policies with high internal validity for causal inference. But it also has to be helpful when national and local 'users' ask whether the global results have external validity and can be applied in their specific context. Research might also be needed to develop tools for assessment of needs and priorities in specific populations, and of the potential impact of interventions and policies in those populations. We might thus -with the 30-year perspective of this issue of Scandinavian Journal of Public Health-ask whether Nordic public health research has asked the right questions and provided the most relevant answers to support policy development and practice for improving population health at both a central and local level -but particularly at the local level. This is not a new question. Public health research in the Nordic countries has indeed a long tradition, particularly in Sweden and Finland, for not only being strongly linked to policy making [2] , but also for having some weak areas [3] . That looks however very different depending on what type of research is being discussed. This paper will make a systematic approach but has no ambition to give a representative picture of research in all the Nordic countries and in all public health disciplines. It should be read with the limited experience of the author in mind -mainly from social medicine and epidemiology in Sweden and Denmark.
The interfaces between research and practice
Epidemiology is often said to be the basic science of public health and has been defined as 'the study of the determinants and distribution of health-related states or events in specific populations and the application of this study to the control of health problems' [4] . Aetiology, surveillance and action are indeed central areas, but local practitioners have also asked for better understanding of the context that enables interventions to be implemented [5, 6] . That demand is not surprising since any policy and action is only as good as its implementation. Implementation science is about understanding why politicians, professions and citizens think and do, as they do or choose not to do. here epidemiology is of little help.
Three areas of public health research are thus central: (1) knowledge on causes of disease and injuries; (2) knowledge on effects of interventions to change those causes; and (3) knowledge on governance and resources needed to implement those interventions and policies. If we at the same time make a distinction between (a) research producing knowledge with high internal and external validity, (b) monitoring of global and local knowledge on causes, effects and implementation, and (c) population-and context-specific analysis, we can create a matrix with nine specific areas (A-I) where the relevance of research for practice and the relevance of practice for research priorities can be examined and discussed [5] . The matrix is shown in Table I , and this paper will walk through them all to examine to what extent research has been sufficiently relevant for practice.
A: Etiological research
Most public health practitioners would probably agree that lack of knowledge about causes of diseases and injuries is not what primarily holds back health policy development and prevention. That does not change the fact that there recently (again) has been a debate on whether the balance is optimal between the three elements epidemiology-aetiology, surveillance and action. Or more precisely, whether the first has been prioritized at the expense of the other two. Today's global public health challenges such as rising rates of obesity and diabetes and increasing health inequalities have triggered a discussion on whether epidemiology is asking the right questions, when the answers it provides clearly have not been sufficient to change those trends [7] . If epidemiology now increasingly serves the needs of personalized precision medicine to identify high-risk individuals, many look back to the distinction Geoffrey Rose made 30 years ago between studying the causes of individual cases and causes of population incidence [8] [9] [10] .
Rose pointed out that there are important causes of incidence for which exposure shows little contrast between individuals within populations but where exposure contrast exists between populations. Such, often contextual, causes may be economic, environmental, cultural and social, including policies. They [10] [11] [12] . It is an epidemiology that questions the necessity for external validity and focus on the 'causal architecture', i.e. the prevalence and structure of causes in specific populations in terms of clustering, causal chains, interaction and cascades of causes on different levels. The last 30 years' development of modern epidemiology both globally and in Scandinavia has however moved in another direction, focusing more on what causes variations between individuals, and on a more formalized causal thinking. It is a development that embraces the counterfactual and potential outcomes paradigm [13] , which with increasingly sophisticated methods improves internal validity and causal inference. Insisting that exposure in observational studies should correspond to well-defined interventions has by some been criticized for driving epidemiology towards more clinical appliances [12] . clinical interventions can indeed more easily than structural policies fulfil the assumptions needed for causal inference. But even studies on the structural level may on the other hand be helped, as the counterfactual thinking forces those studying contextual exposures to conceptualize their exposures more closely to potential policies.
Other developments have drawn in the same direction. The rapid expansion of whole-genome sequencing and genetic epidemiology has turned out to be of high relevance for personalized clinical medicine where genetic and other molecular factors specific to individuals can be used to tailor treatment. For clinical prevention it has so far turned out to be less useful. What is needed here is to identify a specific individual's risk. But adding several new genetic and non-genetic biomarkers improves the discriminatory accuracy only slightly. (Measured as the area under the ROc-curve the improvement is only 5-10% for cancer and cardiovascular disease [14, 15] .)
In retrospect it can be seen how important Rose's distinction was, but also how difficult it has been to develop the macro-epidemiology of populations needed for his perspective of population health. Life course epidemiology and multilevel analysis of contextual exposures on community level has contributed with important knowledge, but population health sciences need to elaborate both concepts and methods and involve other disciplines [16, 17] .
The distinction between individual and population levels of risk is however still not well recognized [18] , which is maybe not so surprising. Studies focusing on population risk as well as those focusing on individual risk are based on comparisons of average group risks, which make it less obvious to distinguish between causes of population incidence and causes of individual cases. Rose's distinction calls for studies of contextual exposures using multilevel analysis, but there is a need to be concerned not only with what causes different average risks, but also what causes the variance within specific population boundaries, since it is important for understanding the health inequalities within populations [19] .
B: Epidemiologic surveillance
Demographic and epidemiological surveillance of health outcomes has been going on for centuries because it had policy relevance to identify what was needed to be a strong nation with a big and healthy population [20] . The idea that health policy planning on national and local levels could be guided by surveillance of exposure to health determinants has a more recent history and got firmly established in Scandinavia 30 years ago [21, 22] . It has recently been further elaborated in Norway in a format with specific relevance for health inequalities and intersectoral action [23] .
There is no doubt that local health data on both outcomes and exposures fuel the political energy that drives health policy development [24] , even if the data may not provide any unexpected trends or population differences. The current national health surveys in the Scandinavian countries serve this purpose well when it comes to individual level behavioural and psychosocial exposures. But so far, they have been less helpful when it comes to contextual exposures related to policy, social conditions and environment.
Disease occurrence in Scandinavia can to a large extent be monitored by surveys and utilization data from hospitals and primary care, and those data are often available locally. consequences of disease in terms of survival have been well registered and monitored for a long time, but functional level and disability is much less well registered. That is an outcome more related to rehabilitation than prevention, but since many of the determinants are the same and municipalities have a key role in that area too, it has local policy relevance. It has growing relevance in times where many health indicators are improving, but the number of people leaving the labour market due to health problems is increasing. It is also an equity issue since the social gradient is steeper the more severe consequences of disease are studied [25] .
Recent more theoretical discussions on policy for health development [26, 27] have applied the capability approach suggested by Amartya Sen in 1985 [28] . This perspective has also been promoted by the World health Organisation [29] and discussed in recent Swedish policy documents [30] . The capability approach argues that evaluation (and surveillance) of development and policies should focus on how they change what people are able to do (capabilities) as opposed to what they actually do and be (functionings). Removing obstacles and increasing the options in people's lives, so that they have more freedom to live the kind of life they have reason to value, is an overall goal for development [31] . For health surveillance the important conclusion is that consequences of diseases in terms of disability and mortality are examples of such obstacles and therefore important to monitor. But it has been suggested that evaluations of social development and health policies should include not only available resources and the realized functionings but also the range of capabilities available to people. The freedoms or opportunities available to an individual and the contextual conditions that drive or limit choices has growing relevance for public health [30] but are not easily observable. Proposals on how to operationalize and measure capabilities have been made, albeit so far not often used [32, 33] . The idea that public health policy and health care planning cannot rely on what is known about current utilization and demand but should be based on an analysis of needs in the target population, was formulated politically and scientifically more than 30 years ago in Sweden [34] . Methods were suggested, and techniques have further been developed to support needs assessment in health care planning. They build on assessments of incidence and prevalence of morbidity, analysis of existing services and effectiveness as well as cost-effectiveness of interventions available [35] .
C: Local analysis of needs
The most comprehensive effort to provide policy making with data for priority setting so far has been the Global Burden of Disease study that started 25 years ago. It has developed a shared 'currency' (disability-adjusted life years, DALYs) by which diagnoses and exposures can be compared in terms of their impact on disability and mortality [36] and has provided estimates for all countries including the Nordic countries 1990-2016 [37] . To apply this tool in political decision making has however turned out to be difficult partly because the algorithms involved are complicated and not fully transparent. Breaking it down to local areas is not easy either, but the ranking of what diseases represent bigger and smaller burdens of disease might not differ much across areas within a country.
Translating local epidemiological descriptions into preventive policy options might be supported by estimates of the potential health effect of the different options. To turn results into policy proposals one needs to consider three aspects: (1) what is the distribution of risk-factor exposure before and after the intervention; (2) what is the exposure effect on different health outcomes? ; and since those effect estimates often are made on other populations, (3) how is the transportability of those estimates? Such an exercise is called health impact assessment (e.g. see holm et al. [38] and recently also a causal impact framework by Westreich et al. [39] ). The burden of disease technique with a shared currency of health outcomes, which therefore can be added, is a useful tool here because a certain policy might influence more than one determinant and each of them might influence different types of disease and injury with widely different disability and survival rates.
D: Intervention research
Public health practitioners will typically need to know what interventions and policies work, for whom they work and under what conditions. Public health science has however not always made it easy for them. One problem is that intervention studies in public health until recently have been relatively few in the Nordic countries [3] , and if effects and conditions for implementation differ across countries there is an issue of transportability. Results from intervention studies in e.g. UK or US might not be easy to implement and effects might turn out to be far from the expected.
Public health practitioners are also met with conflicting signals. On the one hand they often work in health administrations close to the medical tradition. here (described somewhat idyllic) progress in clinical methods starts with carefully controlled randomized trials of new treatments, and if systematic reviews of several trials confirms efficacy with high internal and external validity, and the treatments are 'accredited' by national authorities, they will be implemented, and not further evaluated. Authorities might then start monitoring the fidelity of their implementation in practice.
In health promotion it seldom works like that. Public health interventions are often complex, and evaluations are often done with methods that do not ensure either internal or external validity (see F). high internal validity often demands costly study designs such as cluster-randomized trials [40] . Replication studies have even then disappointingly often not been able to find the same effects when they are done in different populations and sites. The reason for that has often been that complex interventions involve many components and mechanisms, all of which can be modified by the varying contexts in which they are implemented [41] .
Some authors have argued that the whole idea of using controlled trials to decide whether a complex intervention should be 'accredited' as a 'product' to be implemented in different contexts is wrong. They suggest an alternative in terms of 'realist evaluations' focusing on a theory-based understanding of mechanisms involved and their interaction with the local context [42] . That might provide a deeper understanding of why an intervention works or not, where it can work and for whom, but it leaves the critical question of effectiveness unanswered.
Others have therefore argued for a synthesis. controlled trials applied on theoretically well-motivated complex interventions still need to be done to test efficacy [43] . They should be combined with detailed process evaluations [44] . Whenever possible, trials should allow for stratified analysis or otherwise, to improve understanding of mediating mechanisms and modifying contextual conditions [43] . It is indeed high demands to put on intervention research that not only should perform large costly studies on complex interventions, but also provide the statistical power to allow for stratified analysis that can cast light on contextual effect modification. The use of large-scale natural experiments for effectiveness comparisons might then look like a more attractive alternative [45] . In the Nordic countries where regions and municipalities formally have a high degree of freedom to pursue their own public health policies there might be a research potential in ongoing 'natural experiments' with contrasting types or intensity of interventions. Many relevant outcome measures for such an analysis are collected at local level (see B) and adequate measures of policy implementation can be used as exposures (see h). But unfortunately (from a research perspective) municipalities seldom use their formal freedom to pursue very different policies, and natural experiments therefore might not show the necessary 'exposure contrast'.
E: Systematic reviews
Not entirely in parallel with the other areas it can be said that 'monitoring' knowledge about intervention effects is done by those institutions who make systematic reviews such as the international cochrane and campbell collaborations and the national centres, e.g. National Institute for health and care Excellence (NIcE), centers for Disease control and Prevention (cDc), etc. During the 1990s many including the Nordic countries established centres for health Technology Assessments with focus on clinical methods but including some public health interventions in their reviews. These assessments included evaluation of efficacy and effectiveness, acceptability and feasibility for citizens and professionals, as well as conditions for implementation and costs for society and citizens [46] .
Due to the complications mentioned above the systematic review of often complex interventions in public health is not an easy endeavour. The whole idea of collecting results (or making a meta-analysis) from many intervention studies made in different sites and populations is built on the assumption that they have a high degree of external validity so that results can be pooled to provide one shared conclusion on efficacy. Both internal and external validity are indeed criteria in most systematic reviews [47] .
GRADE criteria and other recommendations have recently been expanded to include equity concerns [48] . This means that they are allowing for comparisons between socioeconomic groups to see whether there are differential effects across groups. But a broad range of contextual factors, other existing policies and norms will modify effects too. Few systematic reviews take this into account, and if they do, it usually leads to a downgrade of the evidence level [49] . heterogeneous results on effectiveness might often be related to differential implementation, and hence it is important to make the distinction whether results support the theory of effects or is a consequence of lacking (fidelity of) implementation (see further G).
F: Outcome evaluation
When communities and their policymakers and public health practitioners implement interventions, there is an obvious interest to know whether the outcome in the population was the expected. Such a follow-up of outcome with indicators (often those used in surveillance -see B) will not enable any causal conclusions about whether the intervention or something else caused the outcome, but it is still highly relevant to measure the outcome. These types of outcome evaluation have limited internal and external validity, are seldom published, do not qualify for systematic reviews, and do not contribute to the accumulated evidence base. They are therefore often repeated in another context.
Since the evidence is till fragmented local communities often approach public health researchers to help with evaluations [6] . Since local budgets and evaluation grants usually do not allow full-scale experimental designs, it might seldom be possible to ensure high levels of validity of the results. They might still have local relevance, but for researchers who need to publish their results in an international scientific journal they are met with demands of both internal and external validity that then are difficult to comply with.
G: Implementation research
When asked about their most urgent research needs public health practitioners often ask for more implementation research [5, 6] . They think they have evidence enough to prioritize between determinants and to decide on some intervention to tackle them, but they have difficulties in making it happen. And they find little help in recommendations from international and national authorities. A well-known Nordic example is Denmark's low life expectancy. It has long been clear that the 30-40% higher mortality among middle-aged Danes compared to Swedes is caused by a lack of or delayed implementation of well-known and effective alcohol and tobacco policies that have worked well in many other countries. Research on why this is so is however very sparse.
Implementation science is, compared to the other research areas discussed here, still in the early stages of developing theories and methodologies, in spite of the fact that its relevance has been obvious for decades. This is so for implementation science in general [50] and particularly so in public health [51] . Much implementation science has been concerned with implementation of new diagnostics and treatment methods in clinical practice. A large part of health services research is indeed implementation sciencebut focused on clinical settings. Problems connected to implementation of public health policies that often involve different policy sectors have not made the research questions easier to handle [52] . Much of the discussion on intervention research pertains here too in the sense that the questions of why an intervention works, for whom and under what conditions often is as much an implementation issue as an effectiveness issue [42, 53] .
Implementation science is developing in a direction not so different from other public health research areas with deductive approaches based on theoretical constructs, a clear distinction between measures of implementation and of preconditions for that to happen, multivariate analysis to supplement qualitative data, more use of longitudinal designs and comparative studies across countries and local areas [5, 50] .
H: Quality assurance
In most public service administrations it is part of the everyday routine to monitor the implementation of services. When performance management is increasingly used in the governance process of many policy areas the measurement of what is actually implemented is critical, besides existence of solid evidence on the impact on outcomes of the activities implemented. For clinical health care detailed instruments have been developed and widely applied to categorize activities. Pharmaceutical treatments are, for example, classified by the anatomical chemical classification system of drugs and surgical procedures by the NOMEScO classification of surgical procedures system. In clinical registers this information is linked to patient characteristics such as diagnosis and often also to biological and functional health outcomes. Something similar for clinical prevention in clinical settings is being developed in Sweden (klassifikation av vårdåtgärder codes), and for primary care it is included in the international classification of primary health care system.
For multi-sectoral public health programmes it has been argued that a better reporting of implementation is needed [54, 55] . But public health research has not been very helpful in developing a similar system for health promotion. here most activities are pursued in non-clinical settings and so far, there exist no system that classifies what is done, with what 'doses', for whom, etc. It could be argued that this kind of registration of what is implemented takes a lot of time for front personal, but what is not measured tends to live a dangerous life in the budget process. clinical work can show detailed documentation on what is implemented, on productivity, etc., and comparisons over time and across providers often have considerable impact on further implementation and regulation. It is characteristic that the Swedish system for local and regional comparisons (Öppna jämförelser), for clinical activities includes comparisons of implementation of clinical activities and some outcomes, while for public health it only includes outcome measures in terms of determinants and diseases, but no indicators of implementation [56] . A major effort to monitor and analyse intersectoral health policies was made in Sweden with the National Public health Policy Report in 2005 [57] .
There are no doubt major difficulties with classifying preventive activities across sectors since they include very different means or agentic tools such as economy (e.g. alcohol taxes), legislation (e.g. smoke restrictions), physical changes (e.g. building bicycle paths), social programmes (e.g. employment policy), pedagogical (e.g. health education), psychological method (e.g. mindfulness programmes) and biological interventions (e.g. vaccinations), as well as the preventive pharmaceutical drugs (e.g. cholesterol lowering) and surgical methods (e.g. cervical conisation). Exposure and target group reached would be other components of such a system.
It is indeed possible to describe implementation of health promotion and prevention without such classification systems, but it would make comparative studies and quality assurance easier and thereby support the legitimacy of health promotion programmes.
I: Process evaluation
The actual implementation found for a specific programme could be compared with what was planned or with some standards of intervention. This is very common in clinical practice where several detailed guidelines for treatment of different diseases exist. Similar guidelines for health promotion and prevention standards exist but are less commonly used. Sweden has provided national guidelines for disease prevention, but they are limited to prevention in clinical settings for alcohol, tobacco, diet and physical activity [58] . These guidelines have promoted implementation but still with large regional variation. Denmark has guidelines for a longer list of risk factors, which includes suggestions involving sectors other than health care [59] . The Danish version has no clear standards against which the implementation can be measured, but they may still have a considerable impact on activities actually implemented [60] .
If implementation of policies does not reach expected or needed standards, the question is why. Process evaluation is based on an understanding of how implementation is achieved and with what resources, education etc. [44] . It might be important to know what exactly was delivered, fidelity to the intended intervention and the dose, i.e. the quantity that reaches different target groups. Understanding the mechanisms of impact including the responses to intervention and how these mechanisms interact with the context [42] is central. The distinction between implementation research (G) and process evaluation is blurred because the local context of implementation is a critical component and external validity as a criterion of research is seldom achievable.
An infrastructure for research-practice collaboration
In this paper I have focused on areas where I think research and practice could support each other better. The question is what kind of infrastructure would promote such a development. In all Nordic universities there is a very strong institutionalized collaboration between clinical practice and clinical research. All medical faculties are closely linked to university hospitals and sometimes primary care units for both teaching and research purposes. Many researchers have clinical positions combined with half time university positions.
A similar structure for public health is much less common and where it has existed it has often been difficult to sustain. In the clinical area there are strong medical professions that can be the physical link between research and practice. In public health in the Nordic countries there is not as yet an equally strong profession to fulfil the same function. The great expansion of public education in the last 20 years may however change that. There might also be a problem in matching the broad competencies needed for policy development in population health and the increasingly specialized university institutions.
Maybe the parallel made in much of the intervention and implementation research (see D and G) between medicine and public health is a bit misleading. If the most effective part of public health practice is to accomplish structural changes shaped by economic and social policy, educational policies, environmental and food policies, they might need to be carried out by people for whom health is not necessarily a first professional priority, and the idea of implementing evidence-based packages of interventions might be something rather odd in their context shaped by very different legislations and professional traditions.
Public health research needs population laboratories and close collaboration with public health administrations to prepare the epidemiology figures, but in particular to perform intervention and implementation research. Public health and health care administrations need, on the other hand, people with skills in economics, epidemiology and other disciplines as health governance is becoming increasingly complicated with growing demands in terms of effectiveness, transparency and equity. To create institutional forms for bilateral learning collaboration between practice and research will be a key challenge in the coming years.
Six main conclusions
• Epidemiology must be more concerned with determinants of populations' health than individuals' health.
• Interventions research needs a broad range of methodologies from cluster-randomized trials, to natural experiments and realist evaluations.
• Implementation science has to widen it perspective from studying implementation of medical procedures to intersectoral policies.
• For monitoring purposes we need better tools to measure contextual exposures, and individual disabilities and capabilities as well as implementation of multi-sectoral policies.
• Local-context-dependent analyses of population health needs and results of interventions need improvements in internal validity and need to command respect even if they lack external validity.
• The infrastructure for collaboration between public health research and practice needs to be strengthened.
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